GlaxoSmithKline Pharmaceuticals Q1 Results
- BSE: 500660
- NSE: GLAXO
- ISIN: INE159A01016
- Sector: Biotechnology & Drugs
BSE
2,166.30
-0.20 (-0.01%)
-0.20 (-0.01%)Volume2.38 K
Updated: Fri 5 Jun, 2026 | 15:42:54
NSE
2,164.10-2.50 (-0.12%)
-2.50 (-0.12%)Volume28.74 K
Updated: Fri 5 Jun, 2026 | 15:31:19
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - GlaxoSmithKline Pharmaceuticals Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 569.49 | 657.54 | -13.17% | 600.52 | -5.17% |
| Depreciation/ Amortization | 15.52 | 13.17 | 5.42% | 16.41 | -5.42% |
| Operating Income | 235.68 | 337.76 | -26.00% | 214.13 | 10.06% |
| Net Income | 205.01 | 277.86 | -22.01% | 182.33 | 12.44% |
| Other Operating Expenses Total | 113.69 | 135.63 | -16.57% | 137.56 | -17.35% |
| Net Income Before Taxes | 278.98 | 373.10 | -22.20% | 249.40 | 11.86% |
| Total Revenue | 805.17 | 995.30 | -17.37% | 814.65 | -1.16% |
| Selling/ General/ Admin Expenses Total | 152.57 | 164.75 | -0.26% | 151.28 | 0.85% |
| Diluted Normalized EPS | 12.10 | 16.40 | -22.01% | 10.76 | 12.45% |
EQUITY QUICK LINKS
FROM MARKETS
RELATED LINKS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.